This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Study of Male Osteoporosis and Aging

This study is currently recruiting participants.
See Contacts and Locations
Verified December 2006 by Odense University Hospital
Novo Nordisk A/S
AP Moeller Foundation
Information provided by:
Odense University Hospital Identifier:
First received: April 18, 2007
Last updated: April 19, 2007
Last verified: December 2006
The aim of this study is to identify potential risk factors for fragility fractures in men.


Study Type: Observational
Study Design: Allocation: Random Sample
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Study on Male Osteoporosis and Aging

Resource links provided by NLM:

Further study details as provided by Odense University Hospital:

Estimated Enrollment: 30000
Study Start Date: December 2006
Estimated Study Completion Date: December 2017
Detailed Description:

Osteoporosis is a disease characterized by decreased bone mass and pathological changes in the microarchitecture of the bones. The clinical significance of osteoporosis is the association with fragility fractures and, consequently, increases in both morbidity and mortality.

In men, genetical and life-style factors are known to affect the risk of fractures, however, data relating these factors with measures of bone mineral density and fracture risk are limited.

30.000 men aged 60-70 were randomly selected from the Central Office of Civil Registration in Denmark. Each receive a questionnaire addressing demographics, potential risk factors of osteoporosis, past medical history and medication by mail. In case of consent, the participants will complete a full medical examination including DXA and sampling of DNA if they have a fragility fracture. At the same time, 2 participants from the study population will be selected as control. The study period is 10 years.


Ages Eligible for Study:   60 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Men aged 60-70 being able to consent in writing
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00463411

Contact: Kim T Brixen, MD, Ph.d 0045 65413536
Contact: Morten F Nielsen, MD 0045 22877448

Department of Endocrinology Recruiting
Odense, Denmark, 5000
Contact: Morten F Nielsen, MD    0045 22877448 ext 65413536   
Contact: Kim T Brisen, MD, Ph.d.    0045 65413536   
Sponsors and Collaborators
Odense University Hospital
Novo Nordisk A/S
AP Moeller Foundation
Principal Investigator: Kim T Brixen, MD. Ph.d Odense University Hospital
  More Information Identifier: NCT00463411     History of Changes
Other Study ID Numbers: 025
Study First Received: April 18, 2007
Last Updated: April 19, 2007

Keywords provided by Odense University Hospital:
fracture risk
genetical epidemiology

Additional relevant MeSH terms:
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases processed this record on September 19, 2017